loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (DMF) of 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 161Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    26/09/2024 Hubei Gedian Humanwell Pharmaceutical
    China
    		 HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO LTD 32999 OXCARBAZEPINE 2018-07-22 Active II Complete 2019-04-12 2019-02-12
    26/09/2024 Polpharma
    Poland
    		 ZAKLADY FARMACEUTYCZNE POLPHARMA SA 34418 OXCARBAZEPINE 2019-12-20 Active II Complete 2020-08-04 2020-02-03